At Beijing Cancer Hospital, Dr. Ken Ohata recently shown exceptional competence while executing an endoscopic procedure. His advice has been extremely helpful to colleagues and future doctors. It gives us great pleasure to acknowledge the invaluable support that ZKSK disposable hemoclip and ESD knife have provided to this project.
1. Who is Dr. Ken Ohata?
Ken Ohata is a renowned gastroenterologist from Chikusei City, Ibaraki Prefecture, Japan. He is mostly credited for pioneering endoscopic care, especially Endoscopic Submucosal Dissection (ESD), which provides a less invasive option to traditional open abdominal surgery. Interestingly, Dr. Ohata is skilled at treating the colon, stomach, and oesophagus in a single treatment.
Since 2016, Dr. Ohata, a vital member of the Endoscopy Department of NTT East Japan Kanto Hospital, has routinely completed the greatest number of colorectal ESD procedures in Japan, establishing the hospital as one of the country's top high-volume centres.
2. What is Endoscopic Submucosal Dissection?
An sophisticated endoscopic procedure called Endoscopic Submucosal Dissection (ESD) is mostly used to treat precancerous lesions and early-stage gastrointestinal malignancies. Lesions inside the mucosal and submucosal layers of the gastrointestinal tract, including the oesophagus, stomach, and colon, can be precisely and completely removed using it.
An endoscope fitted with specialised instruments, like knives and electrocautery devices, is introduced into the digestive system during an endoscopic subdural. With the aid of these tools, the targeted lesion is carefully removed while protecting the deeper tissue layers by dissecting the mucosal and submucosal layers. By completely removing the lesions, this method lowers the chance of recurrence and eliminates the need for repeat surgery.
Compared to conventional surgical methods, ESD has a number of benefits, including as minimum invasiveness, quicker recovery periods, and a lower risk of problems. Patients with large precancerous lesions or early-stage gastrointestinal malignancies who may not be candidates for traditional endoscopic resection procedures, such as endoscopic mucosal resection (EMR), will benefit most from it.
